Roel Willemze
- Hematology top 0.05%
- Immunology top 0.2%
- Oncology top 0.5%
- Molecular Biology top 2%
- Genetics top 0.1%
- Co-authors
- Willem E. FibbeJ.H. Frederik FalkenburgAlwine B. KruisselbrinkEllie G.A. LurvinkHanneke C. Kluin‐NelemansJH FalkenburgMirjam H.M. HeemskerkAlma J. Nauta
- Topics
- Hematopoietic Stem Cell Transplantation (111 papers)Acute Myeloid Leukemia Research (75 papers)Immune Cell Function and Interaction (69 papers)
- Cited by
- HematologyGeneticsImmunology
- Journals
- New England Journal of MedicineProceedings of the National Academy of SciencesJournal of Clinical Investigation
- Partner nations
- NetherlandsItalyBelgium
In The Last Decade
Roel Willemze
283 papers receiving 14.0k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Hematology 7.3k
- Immunology 5.4k
- Oncology 3.9k
- Molecular Biology 3.4k
- Genetics 3.3k
Countries citing papers authored by Roel Willemze
This map shows the geographic impact of Roel Willemze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roel Willemze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roel Willemze more than expected).
Fields of papers citing papers by Roel Willemze
This network shows the impact of papers produced by Roel Willemze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roel Willemze. The network helps show where Roel Willemze may publish in the future.
Co-authorship network of co-authors of Roel Willemze
This figure shows the co-authorship network connecting the top 25 collaborators of Roel Willemze. A scholar is included among the top collaborators of Roel Willemze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roel Willemze. Roel Willemze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 69 | |
| 2 | 40 | |
| 3 | 52 | |
| 4 | 60 | |
| 5 | Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative settingbreakdown → | 545 |
| 6 | Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cellsbreakdown → | 569 |
| 7 | 63 | |
| 8 | 22 | |
| 9 | 159 | |
| 10 | 43 | |
| 11 | Allogeneic vs autologous stem cell transplantation according to cytogenetic and FAB features in AML patients (pts) <=45 yrs old in CRI: Results of the EORTC-GIMEMA AML-10 trial | 2 |
| 12 | 22 | |
| 13 | Allogeneic vs autologous stem cell transplantation according to cytogenetic features in AML patients (pts) <= 45 yrs old in first CR: Results of the EORTC-GIMEMA AML-10 trial | 5 |
| 14 | The type of anthracycline administered during remission induction and consolidation therapy of AML has an impact on feasibility of subsequent autologous or allogeneic transplantation and induced marrow toxicity: preliminary results of the EORTC-Gimema AML-10 randomized trial. | 5 |
| 15 | 27 | |
| 16 | 7 | |
| 17 | 12 | |
| 18 | 15 | |
| 19 | Comparison of quality of life (QOL) of patients with acute myelogenous leukemias (AML) in long-term first complete remission (CR) after bone marrow transplantation (BMT) - Allogeneic or autologous - Or intensive chemotherapy consolidation (ICC): EORTC-GIMEMA AML 8A study | 1 |
| 20 | 134 |
About Roel Willemze
Roel Willemze is a scholar working on Hematology, Immunology and Genetics, having authored 288 papers that have together received 14.3k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (111 papers), Acute Myeloid Leukemia Research (75 papers) and Immune Cell Function and Interaction (69 papers). The work is most often cited by research in Hematology (7.3k citations), Genetics (3.3k citations) and Immunology (5.4k citations). Roel Willemze has collaborated with scholars based in Netherlands, Italy and Belgium. Frequent co-authors include Willem E. Fibbe, J.H. Frederik Falkenburg, Alwine B. Kruisselbrink, Ellie G.A. Lurvink, Hanneke C. Kluin‐Nelemans, JH Falkenburg, Mirjam H.M. Heemskerk, Alma J. Nauta, Michel G.D. Kester and Renée M. Y. Barge. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.